Droperidol and QTc Interval Changes in ED Patients

Part of paid clinical trials in Corpus Christi, Texas.

Sponsor
CHRISTUS Health
Study ID
NCT06726811
Status
Recruiting
Apply to this trial

Conditions

  • Emergency Department Patient
  • QTc Intervals Changes

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Droperidol injection — DRUG
    2.5 mg

Study Details

Objectives To assess the association of low-dose Droperidol administration in the emergency department with changes in the QTc interval. Hypothesis Our study is designed to test the null hypothesis that there will be no clinically significant change in QTc interval after administration of 2.5mg of IV Droperidol during an emergency department visit.

Key Dates

Start date
Oct 17, 2024
Status verified
Dec 2024
Primary completion
Sep 30, 2025
Completion
Sep 30, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

ECG Evaluation [ Time Frame: 30 minutes after Droperidol is given. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CHRISTUS Spohn Hospital Corpus Christi-ShorelineCorpus ChristiTexas78405
Aaron Bartoe, DO, MS
[email protected]
(817) 999-8167
Peter Richman, MD, MS
[email protected]
(817) 999-8167

Find similar trials in Corpus Christi, TX

By research site
CHRISTUS Spohn Hospital Corpus Christi-Shoreline· Corpus Christi, TX

Related Studies